nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftazidime—Thrombocytopenia—Irinotecan—lung cancer	0.00105	0.00105	CcSEcCtD
Ceftazidime—Dysgeusia—Paclitaxel—lung cancer	0.00105	0.00105	CcSEcCtD
Ceftazidime—Haemoglobin—Docetaxel—lung cancer	0.00105	0.00105	CcSEcCtD
Ceftazidime—Anaphylactic shock—Gemcitabine—lung cancer	0.00105	0.00105	CcSEcCtD
Ceftazidime—Haemorrhage—Docetaxel—lung cancer	0.00104	0.00104	CcSEcCtD
Ceftazidime—Diarrhoea—Topotecan—lung cancer	0.00104	0.00104	CcSEcCtD
Ceftazidime—Dizziness—Vinblastine—lung cancer	0.00104	0.00104	CcSEcCtD
Ceftazidime—Convulsion—Cisplatin—lung cancer	0.00104	0.00104	CcSEcCtD
Ceftazidime—Urticaria—Vinorelbine—lung cancer	0.00103	0.00103	CcSEcCtD
Ceftazidime—Diarrhoea—Erlotinib—lung cancer	0.00103	0.00103	CcSEcCtD
Ceftazidime—Abdominal pain—Vinorelbine—lung cancer	0.00103	0.00103	CcSEcCtD
Ceftazidime—Body temperature increased—Vinorelbine—lung cancer	0.00103	0.00103	CcSEcCtD
Ceftazidime—Nervous system disorder—Gemcitabine—lung cancer	0.00103	0.00103	CcSEcCtD
Ceftazidime—Thrombocytopenia—Gemcitabine—lung cancer	0.00102	0.00102	CcSEcCtD
Ceftazidime—Skin disorder—Gemcitabine—lung cancer	0.00102	0.00102	CcSEcCtD
Ceftazidime—Vision blurred—Paclitaxel—lung cancer	0.00101	0.00101	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—lung cancer	0.00101	0.00101	CcSEcCtD
Ceftazidime—Hot flush—Doxorubicin—lung cancer	0.00101	0.00101	CcSEcCtD
Ceftazidime—Dizziness—Topotecan—lung cancer	0.00101	0.00101	CcSEcCtD
Ceftazidime—Tremor—Paclitaxel—lung cancer	0.00101	0.00101	CcSEcCtD
Ceftazidime—Hypotension—Irinotecan—lung cancer	0.001	0.001	CcSEcCtD
Ceftazidime—Menopausal symptoms—Doxorubicin—lung cancer	0.000999	0.000999	CcSEcCtD
Ceftazidime—Vomiting—Vinblastine—lung cancer	0.000996	0.000996	CcSEcCtD
Ceftazidime—Dizziness—Erlotinib—lung cancer	0.000996	0.000996	CcSEcCtD
Ceftazidime—Renal impairment—Doxorubicin—lung cancer	0.000991	0.000991	CcSEcCtD
Ceftazidime—Erythema multiforme—Docetaxel—lung cancer	0.000988	0.000988	CcSEcCtD
Ceftazidime—Agitation—Paclitaxel—lung cancer	0.000986	0.000986	CcSEcCtD
Ceftazidime—Headache—Vinblastine—lung cancer	0.000982	0.000982	CcSEcCtD
Ceftazidime—Angioedema—Paclitaxel—lung cancer	0.000981	0.000981	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Methotrexate—lung cancer	0.00098	0.00098	CcSEcCtD
Ceftazidime—Leukopenia—Etoposide—lung cancer	0.00098	0.00098	CcSEcCtD
Ceftazidime—Hypotension—Gemcitabine—lung cancer	0.000978	0.000978	CcSEcCtD
Ceftazidime—Anaphylactic shock—Cisplatin—lung cancer	0.000975	0.000975	CcSEcCtD
Ceftazidime—Flushing—Docetaxel—lung cancer	0.00097	0.00097	CcSEcCtD
Ceftazidime—Vomiting—Topotecan—lung cancer	0.000968	0.000968	CcSEcCtD
Ceftazidime—Paraesthesia—Irinotecan—lung cancer	0.000964	0.000964	CcSEcCtD
Ceftazidime—Lethargy—Doxorubicin—lung cancer	0.000962	0.000962	CcSEcCtD
Ceftazidime—Leukopenia—Paclitaxel—lung cancer	0.000961	0.000961	CcSEcCtD
Ceftazidime—Rash—Topotecan—lung cancer	0.00096	0.00096	CcSEcCtD
Ceftazidime—Hypersensitivity—Vinorelbine—lung cancer	0.000959	0.000959	CcSEcCtD
Ceftazidime—Dermatitis—Topotecan—lung cancer	0.000959	0.000959	CcSEcCtD
Ceftazidime—Vomiting—Erlotinib—lung cancer	0.000958	0.000958	CcSEcCtD
Ceftazidime—Nervous system disorder—Cisplatin—lung cancer	0.000956	0.000956	CcSEcCtD
Ceftazidime—Thrombocytopenia—Cisplatin—lung cancer	0.000955	0.000955	CcSEcCtD
Ceftazidime—Headache—Topotecan—lung cancer	0.000954	0.000954	CcSEcCtD
Ceftazidime—Rash—Erlotinib—lung cancer	0.00095	0.00095	CcSEcCtD
Ceftazidime—Dermatitis—Erlotinib—lung cancer	0.000949	0.000949	CcSEcCtD
Ceftazidime—Convulsion—Etoposide—lung cancer	0.000948	0.000948	CcSEcCtD
Ceftazidime—Angiopathy—Docetaxel—lung cancer	0.000948	0.000948	CcSEcCtD
Ceftazidime—Skin disorder—Cisplatin—lung cancer	0.000947	0.000947	CcSEcCtD
Ceftazidime—Immune system disorder—Docetaxel—lung cancer	0.000944	0.000944	CcSEcCtD
Ceftazidime—Headache—Erlotinib—lung cancer	0.000943	0.000943	CcSEcCtD
Ceftazidime—Paraesthesia—Gemcitabine—lung cancer	0.000939	0.000939	CcSEcCtD
Ceftazidime—Eosinophilia—Methotrexate—lung cancer	0.000932	0.000932	CcSEcCtD
Ceftazidime—Nausea—Vinblastine—lung cancer	0.000931	0.000931	CcSEcCtD
Ceftazidime—Convulsion—Paclitaxel—lung cancer	0.00093	0.00093	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Irinotecan—lung cancer	0.000927	0.000927	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Etoposide—lung cancer	0.000925	0.000925	CcSEcCtD
Ceftazidime—Pruritus—Vinorelbine—lung cancer	0.000921	0.000921	CcSEcCtD
Ceftazidime—Pain—Irinotecan—lung cancer	0.000918	0.000918	CcSEcCtD
Ceftazidime—Hypotension—Cisplatin—lung cancer	0.000911	0.000911	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—lung cancer	0.000907	0.000907	CcSEcCtD
Ceftazidime—Nausea—Topotecan—lung cancer	0.000904	0.000904	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Gemcitabine—lung cancer	0.000903	0.000903	CcSEcCtD
Ceftazidime—Pain—Gemcitabine—lung cancer	0.000895	0.000895	CcSEcCtD
Ceftazidime—Nausea—Erlotinib—lung cancer	0.000895	0.000895	CcSEcCtD
Ceftazidime—Pancytopenia—Methotrexate—lung cancer	0.000894	0.000894	CcSEcCtD
Ceftazidime—Anaphylactic shock—Etoposide—lung cancer	0.000893	0.000893	CcSEcCtD
Ceftazidime—Diarrhoea—Vinorelbine—lung cancer	0.000891	0.000891	CcSEcCtD
Ceftazidime—Dysgeusia—Docetaxel—lung cancer	0.000891	0.000891	CcSEcCtD
Ceftazidime—Neutropenia—Methotrexate—lung cancer	0.00088	0.00088	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Irinotecan—lung cancer	0.000878	0.000878	CcSEcCtD
Ceftazidime—Anaphylactic shock—Paclitaxel—lung cancer	0.000876	0.000876	CcSEcCtD
Ceftazidime—Paraesthesia—Cisplatin—lung cancer	0.000876	0.000876	CcSEcCtD
Ceftazidime—Thrombocytopenia—Etoposide—lung cancer	0.000875	0.000875	CcSEcCtD
Ceftazidime—Skin disorder—Etoposide—lung cancer	0.000868	0.000868	CcSEcCtD
Ceftazidime—Dizziness—Vinorelbine—lung cancer	0.000861	0.000861	CcSEcCtD
Ceftazidime—Nervous system disorder—Paclitaxel—lung cancer	0.000859	0.000859	CcSEcCtD
Ceftazidime—Thrombocytopenia—Paclitaxel—lung cancer	0.000858	0.000858	CcSEcCtD
Ceftazidime—Skin disorder—Paclitaxel—lung cancer	0.000851	0.000851	CcSEcCtD
Ceftazidime—Abdominal pain—Irinotecan—lung cancer	0.000849	0.000849	CcSEcCtD
Ceftazidime—Body temperature increased—Irinotecan—lung cancer	0.000849	0.000849	CcSEcCtD
Ceftazidime—Toxic epidermal necrolysis—Doxorubicin—lung cancer	0.000849	0.000849	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Cisplatin—lung cancer	0.000842	0.000842	CcSEcCtD
Ceftazidime—Infestation NOS—Methotrexate—lung cancer	0.000839	0.000839	CcSEcCtD
Ceftazidime—Infestation—Methotrexate—lung cancer	0.000839	0.000839	CcSEcCtD
Ceftazidime—Hypotension—Etoposide—lung cancer	0.000835	0.000835	CcSEcCtD
Ceftazidime—Pain—Cisplatin—lung cancer	0.000834	0.000834	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000832	0.000832	CcSEcCtD
Ceftazidime—Vomiting—Vinorelbine—lung cancer	0.000828	0.000828	CcSEcCtD
Ceftazidime—Body temperature increased—Gemcitabine—lung cancer	0.000827	0.000827	CcSEcCtD
Ceftazidime—Renal failure—Methotrexate—lung cancer	0.000825	0.000825	CcSEcCtD
Ceftazidime—Rash—Vinorelbine—lung cancer	0.000821	0.000821	CcSEcCtD
Ceftazidime—Dermatitis—Vinorelbine—lung cancer	0.00082	0.00082	CcSEcCtD
Ceftazidime—Hypotension—Paclitaxel—lung cancer	0.000818	0.000818	CcSEcCtD
Ceftazidime—Headache—Vinorelbine—lung cancer	0.000816	0.000816	CcSEcCtD
Ceftazidime—Leukopenia—Docetaxel—lung cancer	0.000814	0.000814	CcSEcCtD
Ceftazidime—Eosinophilia—Doxorubicin—lung cancer	0.000807	0.000807	CcSEcCtD
Ceftazidime—Paraesthesia—Etoposide—lung cancer	0.000802	0.000802	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Methotrexate—lung cancer	0.000793	0.000793	CcSEcCtD
Ceftazidime—Hypersensitivity—Irinotecan—lung cancer	0.000791	0.000791	CcSEcCtD
Ceftazidime—Convulsion—Docetaxel—lung cancer	0.000788	0.000788	CcSEcCtD
Ceftazidime—Paraesthesia—Paclitaxel—lung cancer	0.000786	0.000786	CcSEcCtD
Ceftazidime—Agranulocytosis—Methotrexate—lung cancer	0.000783	0.000783	CcSEcCtD
Ceftazidime—Pancytopenia—Doxorubicin—lung cancer	0.000774	0.000774	CcSEcCtD
Ceftazidime—Nausea—Vinorelbine—lung cancer	0.000773	0.000773	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Etoposide—lung cancer	0.000771	0.000771	CcSEcCtD
Ceftazidime—Body temperature increased—Cisplatin—lung cancer	0.000771	0.000771	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000769	0.000769	CcSEcCtD
Ceftazidime—Pain—Etoposide—lung cancer	0.000764	0.000764	CcSEcCtD
Ceftazidime—Neutropenia—Doxorubicin—lung cancer	0.000762	0.000762	CcSEcCtD
Ceftazidime—Haemoglobin—Methotrexate—lung cancer	0.000757	0.000757	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Paclitaxel—lung cancer	0.000756	0.000756	CcSEcCtD
Ceftazidime—Haemorrhage—Methotrexate—lung cancer	0.000753	0.000753	CcSEcCtD
Ceftazidime—Pain—Paclitaxel—lung cancer	0.000749	0.000749	CcSEcCtD
Ceftazidime—Anaphylactic shock—Docetaxel—lung cancer	0.000742	0.000742	CcSEcCtD
Ceftazidime—Pruritus—Gemcitabine—lung cancer	0.00074	0.00074	CcSEcCtD
Ceftazidime—Diarrhoea—Irinotecan—lung cancer	0.000735	0.000735	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Etoposide—lung cancer	0.00073	0.00073	CcSEcCtD
Ceftazidime—Nervous system disorder—Docetaxel—lung cancer	0.000728	0.000728	CcSEcCtD
Ceftazidime—Thrombocytopenia—Docetaxel—lung cancer	0.000727	0.000727	CcSEcCtD
Ceftazidime—Infestation NOS—Doxorubicin—lung cancer	0.000726	0.000726	CcSEcCtD
Ceftazidime—Infestation—Doxorubicin—lung cancer	0.000726	0.000726	CcSEcCtD
Ceftazidime—Skin disorder—Docetaxel—lung cancer	0.000721	0.000721	CcSEcCtD
Ceftazidime—Stevens-Johnson syndrome—Doxorubicin—lung cancer	0.00072	0.00072	CcSEcCtD
Ceftazidime—Hypersensitivity—Cisplatin—lung cancer	0.000718	0.000718	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Paclitaxel—lung cancer	0.000716	0.000716	CcSEcCtD
Ceftazidime—Diarrhoea—Gemcitabine—lung cancer	0.000716	0.000716	CcSEcCtD
Ceftazidime—Renal failure—Doxorubicin—lung cancer	0.000714	0.000714	CcSEcCtD
Ceftazidime—Erythema multiforme—Methotrexate—lung cancer	0.000712	0.000712	CcSEcCtD
Ceftazidime—Dizziness—Irinotecan—lung cancer	0.00071	0.00071	CcSEcCtD
Ceftazidime—Urticaria—Etoposide—lung cancer	0.00071	0.00071	CcSEcCtD
Ceftazidime—Jaundice—Doxorubicin—lung cancer	0.000708	0.000708	CcSEcCtD
Ceftazidime—Abdominal pain—Etoposide—lung cancer	0.000706	0.000706	CcSEcCtD
Ceftazidime—Body temperature increased—Etoposide—lung cancer	0.000706	0.000706	CcSEcCtD
Ceftazidime—Urticaria—Paclitaxel—lung cancer	0.000696	0.000696	CcSEcCtD
Ceftazidime—Hypotension—Docetaxel—lung cancer	0.000694	0.000694	CcSEcCtD
Ceftazidime—Body temperature increased—Paclitaxel—lung cancer	0.000692	0.000692	CcSEcCtD
Ceftazidime—Abdominal pain—Paclitaxel—lung cancer	0.000692	0.000692	CcSEcCtD
Ceftazidime—Hepatobiliary disease—Doxorubicin—lung cancer	0.000687	0.000687	CcSEcCtD
Ceftazidime—Angiopathy—Methotrexate—lung cancer	0.000683	0.000683	CcSEcCtD
Ceftazidime—Vomiting—Irinotecan—lung cancer	0.000683	0.000683	CcSEcCtD
Ceftazidime—Immune system disorder—Methotrexate—lung cancer	0.00068	0.00068	CcSEcCtD
Ceftazidime—Agranulocytosis—Doxorubicin—lung cancer	0.000678	0.000678	CcSEcCtD
Ceftazidime—Rash—Irinotecan—lung cancer	0.000677	0.000677	CcSEcCtD
Ceftazidime—Dermatitis—Irinotecan—lung cancer	0.000677	0.000677	CcSEcCtD
Ceftazidime—Headache—Irinotecan—lung cancer	0.000673	0.000673	CcSEcCtD
Ceftazidime—Diarrhoea—Cisplatin—lung cancer	0.000667	0.000667	CcSEcCtD
Ceftazidime—Paraesthesia—Docetaxel—lung cancer	0.000667	0.000667	CcSEcCtD
Ceftazidime—Vomiting—Gemcitabine—lung cancer	0.000665	0.000665	CcSEcCtD
Ceftazidime—Rash—Gemcitabine—lung cancer	0.00066	0.00066	CcSEcCtD
Ceftazidime—Dermatitis—Gemcitabine—lung cancer	0.000659	0.000659	CcSEcCtD
Ceftazidime—Hypersensitivity—Etoposide—lung cancer	0.000658	0.000658	CcSEcCtD
Ceftazidime—Haemoglobin—Doxorubicin—lung cancer	0.000655	0.000655	CcSEcCtD
Ceftazidime—Headache—Gemcitabine—lung cancer	0.000655	0.000655	CcSEcCtD
Ceftazidime—Haemorrhage—Doxorubicin—lung cancer	0.000652	0.000652	CcSEcCtD
Ceftazidime—Hypersensitivity—Paclitaxel—lung cancer	0.000645	0.000645	CcSEcCtD
Ceftazidime—Dysgeusia—Methotrexate—lung cancer	0.000642	0.000642	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Docetaxel—lung cancer	0.000641	0.000641	CcSEcCtD
Ceftazidime—Nausea—Irinotecan—lung cancer	0.000638	0.000638	CcSEcCtD
Ceftazidime—Pain—Docetaxel—lung cancer	0.000635	0.000635	CcSEcCtD
Ceftazidime—Pruritus—Etoposide—lung cancer	0.000632	0.000632	CcSEcCtD
Ceftazidime—Nausea—Gemcitabine—lung cancer	0.000621	0.000621	CcSEcCtD
Ceftazidime—Vomiting—Cisplatin—lung cancer	0.00062	0.00062	CcSEcCtD
Ceftazidime—Pruritus—Paclitaxel—lung cancer	0.00062	0.00062	CcSEcCtD
Ceftazidime—Vision blurred—Methotrexate—lung cancer	0.000618	0.000618	CcSEcCtD
Ceftazidime—Erythema multiforme—Doxorubicin—lung cancer	0.000617	0.000617	CcSEcCtD
Ceftazidime—Rash—Cisplatin—lung cancer	0.000615	0.000615	CcSEcCtD
Ceftazidime—Dermatitis—Cisplatin—lung cancer	0.000614	0.000614	CcSEcCtD
Ceftazidime—Diarrhoea—Etoposide—lung cancer	0.000611	0.000611	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Docetaxel—lung cancer	0.000607	0.000607	CcSEcCtD
Ceftazidime—Flushing—Doxorubicin—lung cancer	0.000605	0.000605	CcSEcCtD
Ceftazidime—Diarrhoea—Paclitaxel—lung cancer	0.000599	0.000599	CcSEcCtD
Ceftazidime—Angiopathy—Doxorubicin—lung cancer	0.000592	0.000592	CcSEcCtD
Ceftazidime—Dizziness—Etoposide—lung cancer	0.000591	0.000591	CcSEcCtD
Ceftazidime—Immune system disorder—Doxorubicin—lung cancer	0.000589	0.000589	CcSEcCtD
Ceftazidime—Abdominal pain—Docetaxel—lung cancer	0.000587	0.000587	CcSEcCtD
Ceftazidime—Body temperature increased—Docetaxel—lung cancer	0.000587	0.000587	CcSEcCtD
Ceftazidime—Leukopenia—Methotrexate—lung cancer	0.000587	0.000587	CcSEcCtD
Ceftazidime—Dizziness—Paclitaxel—lung cancer	0.000579	0.000579	CcSEcCtD
Ceftazidime—Nausea—Cisplatin—lung cancer	0.000579	0.000579	CcSEcCtD
Ceftazidime—Convulsion—Methotrexate—lung cancer	0.000568	0.000568	CcSEcCtD
Ceftazidime—Vomiting—Etoposide—lung cancer	0.000568	0.000568	CcSEcCtD
Ceftazidime—Rash—Etoposide—lung cancer	0.000563	0.000563	CcSEcCtD
Ceftazidime—Dermatitis—Etoposide—lung cancer	0.000563	0.000563	CcSEcCtD
Ceftazidime—Headache—Etoposide—lung cancer	0.00056	0.00056	CcSEcCtD
Ceftazidime—Vomiting—Paclitaxel—lung cancer	0.000557	0.000557	CcSEcCtD
Ceftazidime—Dysgeusia—Doxorubicin—lung cancer	0.000556	0.000556	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	0.000554	0.000554	CcSEcCtD
Ceftazidime—Rash—Paclitaxel—lung cancer	0.000552	0.000552	CcSEcCtD
Ceftazidime—Dermatitis—Paclitaxel—lung cancer	0.000552	0.000552	CcSEcCtD
Ceftazidime—Headache—Paclitaxel—lung cancer	0.000549	0.000549	CcSEcCtD
Ceftazidime—Hypersensitivity—Docetaxel—lung cancer	0.000547	0.000547	CcSEcCtD
Ceftazidime—Anaphylactic shock—Methotrexate—lung cancer	0.000535	0.000535	CcSEcCtD
Ceftazidime—Vision blurred—Doxorubicin—lung cancer	0.000535	0.000535	CcSEcCtD
Ceftazidime—Nausea—Etoposide—lung cancer	0.000531	0.000531	CcSEcCtD
Ceftazidime—Pruritus—Docetaxel—lung cancer	0.000525	0.000525	CcSEcCtD
Ceftazidime—Nervous system disorder—Methotrexate—lung cancer	0.000525	0.000525	CcSEcCtD
Ceftazidime—Thrombocytopenia—Methotrexate—lung cancer	0.000524	0.000524	CcSEcCtD
Ceftazidime—Agitation—Doxorubicin—lung cancer	0.000522	0.000522	CcSEcCtD
Ceftazidime—Nausea—Paclitaxel—lung cancer	0.00052	0.00052	CcSEcCtD
Ceftazidime—Skin disorder—Methotrexate—lung cancer	0.00052	0.00052	CcSEcCtD
Ceftazidime—Leukopenia—Doxorubicin—lung cancer	0.000508	0.000508	CcSEcCtD
Ceftazidime—Diarrhoea—Docetaxel—lung cancer	0.000508	0.000508	CcSEcCtD
Ceftazidime—Hypotension—Methotrexate—lung cancer	0.0005	0.0005	CcSEcCtD
Ceftazidime—Convulsion—Doxorubicin—lung cancer	0.000492	0.000492	CcSEcCtD
Ceftazidime—Dizziness—Docetaxel—lung cancer	0.000491	0.000491	CcSEcCtD
Ceftazidime—Paraesthesia—Methotrexate—lung cancer	0.00048	0.00048	CcSEcCtD
Ceftazidime—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	0.00048	0.00048	CcSEcCtD
Ceftazidime—Vomiting—Docetaxel—lung cancer	0.000472	0.000472	CcSEcCtD
Ceftazidime—Rash—Docetaxel—lung cancer	0.000468	0.000468	CcSEcCtD
Ceftazidime—Dermatitis—Docetaxel—lung cancer	0.000468	0.000468	CcSEcCtD
Ceftazidime—Headache—Docetaxel—lung cancer	0.000465	0.000465	CcSEcCtD
Ceftazidime—Anaphylactic shock—Doxorubicin—lung cancer	0.000463	0.000463	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Methotrexate—lung cancer	0.000462	0.000462	CcSEcCtD
Ceftazidime—Pain—Methotrexate—lung cancer	0.000458	0.000458	CcSEcCtD
Ceftazidime—Nervous system disorder—Doxorubicin—lung cancer	0.000454	0.000454	CcSEcCtD
Ceftazidime—Thrombocytopenia—Doxorubicin—lung cancer	0.000454	0.000454	CcSEcCtD
Ceftazidime—Skin disorder—Doxorubicin—lung cancer	0.00045	0.00045	CcSEcCtD
Ceftazidime—Nausea—Docetaxel—lung cancer	0.000441	0.000441	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Methotrexate—lung cancer	0.000438	0.000438	CcSEcCtD
Ceftazidime—Hypotension—Doxorubicin—lung cancer	0.000433	0.000433	CcSEcCtD
Ceftazidime—Urticaria—Methotrexate—lung cancer	0.000425	0.000425	CcSEcCtD
Ceftazidime—Abdominal pain—Methotrexate—lung cancer	0.000423	0.000423	CcSEcCtD
Ceftazidime—Body temperature increased—Methotrexate—lung cancer	0.000423	0.000423	CcSEcCtD
Ceftazidime—Paraesthesia—Doxorubicin—lung cancer	0.000416	0.000416	CcSEcCtD
Ceftazidime—Gastrointestinal disorder—Doxorubicin—lung cancer	0.0004	0.0004	CcSEcCtD
Ceftazidime—Pain—Doxorubicin—lung cancer	0.000396	0.000396	CcSEcCtD
Ceftazidime—Hypersensitivity—Methotrexate—lung cancer	0.000394	0.000394	CcSEcCtD
Ceftazidime—Gastrointestinal pain—Doxorubicin—lung cancer	0.000379	0.000379	CcSEcCtD
Ceftazidime—Pruritus—Methotrexate—lung cancer	0.000379	0.000379	CcSEcCtD
Ceftazidime—Urticaria—Doxorubicin—lung cancer	0.000368	0.000368	CcSEcCtD
Ceftazidime—Abdominal pain—Doxorubicin—lung cancer	0.000366	0.000366	CcSEcCtD
Ceftazidime—Body temperature increased—Doxorubicin—lung cancer	0.000366	0.000366	CcSEcCtD
Ceftazidime—Diarrhoea—Methotrexate—lung cancer	0.000366	0.000366	CcSEcCtD
Ceftazidime—Dizziness—Methotrexate—lung cancer	0.000354	0.000354	CcSEcCtD
Ceftazidime—Hypersensitivity—Doxorubicin—lung cancer	0.000341	0.000341	CcSEcCtD
Ceftazidime—Vomiting—Methotrexate—lung cancer	0.00034	0.00034	CcSEcCtD
Ceftazidime—Rash—Methotrexate—lung cancer	0.000337	0.000337	CcSEcCtD
Ceftazidime—Dermatitis—Methotrexate—lung cancer	0.000337	0.000337	CcSEcCtD
Ceftazidime—Headache—Methotrexate—lung cancer	0.000335	0.000335	CcSEcCtD
Ceftazidime—Pruritus—Doxorubicin—lung cancer	0.000328	0.000328	CcSEcCtD
Ceftazidime—Nausea—Methotrexate—lung cancer	0.000318	0.000318	CcSEcCtD
Ceftazidime—Diarrhoea—Doxorubicin—lung cancer	0.000317	0.000317	CcSEcCtD
Ceftazidime—Dizziness—Doxorubicin—lung cancer	0.000306	0.000306	CcSEcCtD
Ceftazidime—Vomiting—Doxorubicin—lung cancer	0.000295	0.000295	CcSEcCtD
Ceftazidime—Rash—Doxorubicin—lung cancer	0.000292	0.000292	CcSEcCtD
Ceftazidime—Dermatitis—Doxorubicin—lung cancer	0.000292	0.000292	CcSEcCtD
Ceftazidime—Headache—Doxorubicin—lung cancer	0.00029	0.00029	CcSEcCtD
Ceftazidime—Nausea—Doxorubicin—lung cancer	0.000275	0.000275	CcSEcCtD
